Enliven Therapeutics ELVN
NASDAQ ELVN
$41.93 +0.11 (+0.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Ending Cash Balance (2019 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) Ending Cash Balance (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 Enliven Therapeutics 3.07 Bn 783.70 Mn - 135.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 135.51 Mn
Mar 31, 2026 132.18 Mn
Dec 31, 2025 98.90 Mn
Jun 30, 2025 119.44 Mn
Mar 31, 2025 101.71 Mn
Dec 31, 2024 124.17 Mn
Dec 31, 2023 100.20 Mn
Dec 31, 2022 75.59 Mn
Dec 31, 2021 110.08 Mn
Dec 31, 2020 47.79 Mn
Dec 31, 2019 5.02 Mn
API Access

Enliven Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ELVN&period=max&api_key=YOUR_API_KEY